New data will further support clinical benefits of ULTOMIRIS® in paroxysmal nocturnal hemoglobinuria and its potential to improve outcomes for pediatric patients with hematopoietic stem cell ...

CLEVELAND – A new study from University Hospitals (UH) Connor Whole Health found children, adolescents, and young adults with cancer or sickle cell disease (SCD) treated at a pediatric academic ...

Today, precision medicine in cancer care works like this: genomic testing, preferably next-generation sequencing (NGS), is used to find mutations or lesions that could be therapeutic targets. If ...

While chemotherapy and radiation therapy are standard treatments for cancer newer advancements like CAR T-Cell Therapy are emerging out as transformative options A hematology oncologist shares procedu ...

Cancer rates continue to rise in Angola and across Steuben County, creating a growing need for expanded local oncology services. This expansion builds on a longstanding relationship between FWMOH and ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed what they called “alarming” underutilization of disease-modifying therapies for sickle cell ...

The annual meeting of the American Society of Clinical Oncology drew more than 30,000 attendees to San Diego, and more who participated in the conference virtually, all of them looking to see and hear ...

Urban-Rural Differences in Receipt of Cancer Surgery at High-Volume Hospitals and Sensitivity to Hospital Volume Thresholds One referral office at the Academic CC located in Bexar County, TX, handles ...

The 2025 EHA Congress in Milan will feature over 130 sessions and 4000 abstracts, with a redesigned program structure and expanded speaker program. YoungEHA sessions and thematic debates will cover ...

Investigational T-cell engager, surovatamig, and CAR T-cell therapy, AZD0120, will show potential with initial data across multiple blood cancers New results will showcase benefit of CALQUENCE ® in ...